Journal
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY
Volume 19, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s12958-021-00863-5
Keywords
Hyperandrogenism; Hydroxymethylglutaryl-CoA Reductase inhibitors; Polycystic ovary syndrome; Randomized controlled trials; Meta-analysis
Categories
Funding
- Science and Technology Department of Sichuan Province [2020YFS0492]
- Grassroots Health Development Research Center of Sichuan Province [SWFZ20-Q-039]
- Chengdu Municipal Health Commission [2021046]
Ask authors/readers for more resources
Through a systematic review and meta-analysis, this study showed that statin treatment significantly reduced androgen levels and improved cutaneous manifestations in PCOS patients. Subgroup and sensitivity analysis confirmed the stability of the findings.
Several clinical studies showed that statins were potential to treat polycystic ovary syndrome (PCOS). Through comprehensive search PubMed, EMBASE, the Web of Science, BIOSIS, the ClinialTrails.gov, and the Cochrane Library database up to 14 Feb 2020, we identified the randomized controlled trials about the treatment of statins on hyperandrogenism in PCOS women, and performed a systematic review and meta-analysis. The quality of the included studies was assessed by the Cochrane risk of bias tool and the Jadda score. Subgroup analysis and sensitivity analysis were conducted to analyze the pooled results. Nine trials included 682 PCOS patients were identified. Statins showed a significant potential to reduce testosterone (SMD = -0.47; 95% CI, - 0.76-- 0.18; P = 0.002) and dehydroepiandrosterone (SMD = -0.51; 95% CI, - 0.97-- 0.05; P = 0.03) levels, compared to the control treatments. The cutaneous symptoms hirsutism (SMD = -0.61; 95% CI, - 1.13-- 0.10; P = 0.02) and acne (SMD = -0.92; 95% CI, - 1.49-- 0.34; P = 0.002) were significantly improved by statins in PCOS women. Subgroup analysis showed that the two types of statins, and the different control treatments as well, presented no significantly different effect on testosterone and dehydroepiandrosterone. Sensitivity analysis confirmed the stability of the findings from the meta-analysis. In conclusion, statin treatment could significantly reduce androgen levels and improve cutaneous manifestations of hyperandrogenism of PCOS.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available